SEARCH

SEARCH BY CITATION

References

  • 1
    President's Council of Advisors on Science and Technology. Report to the President on Propelling Innovation in Drug Discovery, Development, and Evaluation. Updated September 25, 2012 whitehouse.gov/sites/default/files/microsites/ostp/pcast-fda-final.pdf. Accessed April 17, 2013.
  • 2
    Prowell TM, Pazdur R. Pathological complete response and accelerated drug approval in early breast cancer. N Engl J Med.2012;366:2438-2441.
  • 3
    DeMichele A, Berry DA, Zujewki J, et al. Developing safety criteria for introducing new agents into neoadjuvant trials [published online ahead of print on March 7, 2013]. Clin Cancer Res. doi:10.1158/1078-0432.CCR-12-2620.